Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
01/2006
01/12/2006DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide
01/11/2006EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives
01/11/2006EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds
01/11/2006EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai
01/11/2006EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
01/11/2006CN1235890C Thizaolyl amide derivatives
01/10/2006US6984663 Cyclohexyl sulphones
01/10/2006US6984649 Pyridine derivatives
01/10/2006CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders
01/05/2006US20060004044 3-glyoxylamideindoles for treating cancer
01/05/2006US20060004020 Pyrrolidine derivatives as oxytocin antagonists
01/05/2006US20060004017 Quinazoline derivatives as angiogenesis inhibitors
01/05/2006US20060004015 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity
01/05/2006DE102004027772A1 Bistropylidenamine und deren Verwendung Bistropylidenamine and their use
01/05/2006DE102004027771A1 Tropylidenamine und deren Verwendung Tropylidenamine and their use
01/04/2006EP1611130A2 Reverse-turn mimetics and method relating thereto
01/03/2006CA2162463C Azolylamine derivative
01/03/2006CA2117651C Itraconazole and saperconazole stereoisomers
12/2005
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005CN1714079A Mandelic acid derivatives
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977259 Quinoline derivatives and their use as aurora 2 kinase inhibitors
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/15/2005US20050277642 Pyrimidine kinase inhibitors
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/13/2005US6974822 Treating osteoarthritis or rheumatoid arthritis
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/08/2005WO2005116020A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272036 Ketones
12/08/2005CA2565263A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
12/07/2005EP1527053B1 Process for preparing rizatriptan
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1268440B1 Imidazole carbenes
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705657A Azole derivatives as antifungal agents
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267178 Novel benzylether derivatives
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
11/2005
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1064268B1 Novel cationic compounds, their use as coupling agents for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229355C Substituted fluoroalcoxyphenylsulfonylurea
11/30/2005CN1229354C Acyl mercapto-triazolyl derivative and use thereof as microbiocides
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/24/2005US20050261346 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
11/24/2005US20050261330 Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/23/2005EP1598351A1 Substituted N-pyrimidinyl-N'-thienyl(amino)sulfonylureas as herbicides
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/23/2005CN1228330C Imidazole derivatives or their salts
11/17/2005US20050256334 Process for the preparation of bis(perfluoroalkyl)phosphinic acids and salts thereof
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1227250C Process for preparing azacycloalkanoyl aminothiazoles
11/16/2005CN1227241C Arylpiperazines having activity at the serotnin 1A receptor
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2179640C Watersoluble azole antifungals
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250776 ethyl (2-{[(2,4-dichloro-5-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetate; treatment of diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, without causing hypoglycemia
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/09/2005EP1592695A1 Pyrimidines, methods for the production thereof, and use thereof
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/03/2005WO2005058916A3 Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590324A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
10/2005
10/27/2005WO2005100370A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
10/27/2005US20050239856 Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives
10/27/2005US20050239855 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/27/2005US20050239770 e.g. 3-{4-Cyclopentylamino-6-[(2,2-dimethyl-propyl)-methyl-amino]-pyrimidin-2-ylamino}-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 163